“…Since 2014, they implement policies that oblige applicants to report their plans for the balance of male and female cells and animals in preclinical studies (Clayton & Collins, ). Most nervous system diseases, including multiple sclerosis, Parkinson's disease, schizophrenia, autism, depression, and dementia affect women and men differentially with respect to prevalence, severity, or disease course (Christensen et al, ; Golden & Voskuhl, ; Haaxma et al, ; Kokras & Dalla, ; Leger & Neill, ; Tschanz et al, ). So, it would seem adequate for preclinical research using mouse models of these diseases to include subjects of both sexes in all experiments.…”